Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

EQS-News: Fiscal year 2023: RENK Group AG continues profitable  growth trajectory
EQS-News: Fiscal year 2023: RENK Group AG continues profitable growth trajectory
EQS-News: Fiscal year 2023: RENK Group AG continues profitable growth trajectory
EQS-News: Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth
EQS-News: Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth
EQS-News: Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth
Modern Dental Group Announces 2023 Annual Results - Record High Revenue, EBITDA and Net Profit, Number of Cases Surpassing 2 Million
Modern Dental Group Announces 2023 Annual Results - Record High Revenue, EBITDA and Net Profit, Number of Cases Surpassing 2 Million
Modern Dental Group Announces 2023 Annual Results - Record High Revenue, EBITDA and Net Profit, Number of Cases Surpassing 2 Million
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares: https://mms.businesswire.com/media/20220601006234/en/1474001/5/JPG_Logo_SG_RGB.jpg
Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares


Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology

GrafTech Announces Appointment of Timothy K. Flanagan as Chief Executive Officer and President: https://mms.businesswire.com/media/20191107005161/en/655890/5/GrafTech%2520International%2520%28Color%29.jpg
GrafTech Announces Appointment of Timothy K. Flanagan as Chief Executive Officer and President


GrafTech International Ltd. (NYSE: EAF) (“GrafTech” or the “Company”) announced today that the Company’s Board of Directors (the “Board”) has appointed Timothy K. Flanagan as the Company’s Chief

Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc: POS-Transaction in Own Shares
EQS-News: VIB Vermögen AG acquires eight properties from Branicks
EQS-News: VIB Vermögen AG acquires eight properties from Branicks
EQS-News: VIB Vermögen AG acquires eight properties from Branicks
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring: https://mms.businesswire.com/media/20231018100004/en/1918576/5/Personalis_Logo.jpg
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring


Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced a new publication validating the company’s NeXT Personal test, an ultra-sensitive

Cloudflare Channel and Alliance Business Revenue Accelerates 174% Over Two Years and Expands with Additional Paths to Revenue, Program Awarded 5-Stars by CRN: https://mms.businesswire.com/media/20200719005029/en/738100/5/cf-logo-h-rgb.jpg
Cloudflare Channel and Alliance Business Revenue Accelerates 174% Over Two Years and Expands with Additional Paths to Revenue, Program Awarded 5-Stars by CRN


Cloudflare, Inc. (NYSE: NET), the leading connectivity cloud company, today announced that its channel revenue increased 174% over the last two years, and was recently awarded by CRN, receiving the

UiPath Announces FedRAMP® Authorization for Its Automation Cloud™ Public Sector: https://mms.businesswire.com/media/20210427005075/en/718791/5/new_uipath_logo_orange.jpg
UiPath Announces FedRAMP® Authorization for Its Automation Cloud™ Public Sector


UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that UiPath Automation Cloud™ Public Sector achieved authorized status in the Federal Risk and

Form 8.3 - The Vanguard Group, Inc.: Mondi plc
Form 8.3 - The Vanguard Group, Inc.: Mondi plc
Form 8.3 - The Vanguard Group, Inc.: Mondi plc
EQS-News: ERFOLGE VON DEFENCE BEI SEINEM ACCUTOX®-ARM(TM)-VAKZIN ZUR KREBSBEKÄMPFUNG FÜHREN ZUR ENTWICKLUNG EINES WIRKUNGSVOLLEN ARM-002(TM)-KREBSIMPFSTOFFS DER ZWEITEN GENERATION
EQS-News: ERFOLGE VON DEFENCE BEI SEINEM ACCUTOX®-ARM(TM)-VAKZIN ZUR KREBSBEKÄMPFUNG FÜHREN ZUR ENTWICKLUNG EINES WIRKUNGSVOLLEN ARM-002(TM)-KREBSIMPFSTOFFS DER ZWEITEN GENERATION
EQS-News: ERFOLGE VON DEFENCE BEI SEINEM ACCUTOX®-ARM(TM)-VAKZIN ZUR KREBSBEKÄMPFUNG FÜHREN ZUR ENTWICKLUNG EINES WIRKUNGSVOLLEN ARM-002(TM)-KREBSIMPFSTOFFS DER ZWEITEN GENERATION
EQS-News:   ELARIS AG agrees on cooperation with the Emil Frey Group as part of its sales and service expansion
EQS-News: ELARIS AG agrees on cooperation with the Emil Frey Group as part of its sales and service expansion
EQS-News: ELARIS AG agrees on cooperation with the Emil Frey Group as part of its sales and service expansion
EQS-News: DEFENCE’S SUCCESSFUL RESULTS ON ITS  ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE
EQS-News: DEFENCE’S SUCCESSFUL RESULTS ON ITS  ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE
EQS-News: DEFENCE’S SUCCESSFUL RESULTS ON ITS  ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE
EQS-News: Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
EQS-News: Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
EQS-News: Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
EQS-News: FRIEDRICH VORWERK generates revenues of €373 million in 2023 with an EBITDA margin of 8.6% and expects further sales and earnings growth in 2024 with an order backlog of €1 billion
EQS-News: FRIEDRICH VORWERK generates revenues of €373 million in 2023 with an EBITDA margin of 8.6% and expects further sales and earnings growth in 2024 with an order backlog of €1 billion
EQS-News: FRIEDRICH VORWERK generates revenues of €373 million in 2023 with an EBITDA margin of 8.6% and expects further sales and earnings growth in 2024 with an order backlog of €1 billion
49th Annual General Meeting of BELIMO Holding AG Approves All Motions
49th Annual General Meeting of BELIMO Holding AG Approves All Motions
49th Annual General Meeting of BELIMO Holding AG Approves All Motions
Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc: POS-Transaction in Own Shares
CURO Group Holdings Corp. to Reduce Debt and Strengthen Financial Position Through Restructuring Support Agreement; Implements Prepackaged Restructuring Plan by Commencing Voluntary Chapter 11 Reorganization: https://mms.businesswire.com/media/20191216005180/en/763172/5/CGHC.jpg
CURO Group Holdings Corp. to Reduce Debt and Strengthen Financial Position Through Restructuring Support Agreement; Implements Prepackaged Restructuring Plan by Commencing Voluntary Chapter 11 Reorganization


CURO Group Holdings Corp. (OTC: CURO) (“CURO” or the “Company”) today announced that, on March 22, 2024, it entered into a Restructuring Support Agreement (“RSA”) that is supported by holders (or

Nutrien to Host Investor Day on June 12: https://mms.businesswire.com/media/20191104006030/en/699432/5/Nutrien_logo.jpg
Nutrien to Host Investor Day on June 12


Nutrien Ltd. (TSX and NYSE: NTR) announced today it is hosting an Investor Day in New York on June 12, 2024, at 10:00 a.m. ET.



Nutrien’s Executive Leadership team will provide an update on the

GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health: https://mms.businesswire.com/media/20230105005172/en/1673594/5/GE_HealthCare_Logo_%28Jan_2023%29.jpg
GE HealthCare Announces the FDA Clearance of nCommand Lite by IONIC Health


GE HealthCare (Nasdaq: GEHC) announces the U.S. FDA 510(k) Clearance of IONIC Health’s nCommand Lite technology. The vendor-agnostic, multi-modality nCommand Lite system will be distributed

Orbia Releases Annual Impact Report, Highlighting Strong Progress on Sustainability-Driven Agenda: https://mms.businesswire.com/media/20200429005967/en/788507/5/Orbia_PrimaryLogo_Blue.jpg
Orbia Releases Annual Impact Report, Highlighting Strong Progress on Sustainability-Driven Agenda


Today Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) released its 15th annual Impact Report, which encompasses the company’s overall business performance as well as key accomplishments in

Form 8.3 - The Vanguard Group, Inc.: Mondi plc
Form 8.3 - The Vanguard Group, Inc.: Mondi plc
Form 8.3 - The Vanguard Group, Inc.: Mondi plc
Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK plc
Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK plc
Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK plc
EQS-News: Aareal Bank AG AGM on 3 May to include squeeze-out resolution
EQS-News: Aareal Bank AG AGM on 3 May to include squeeze-out resolution
EQS-News: Aareal Bank AG AGM on 3 May to include squeeze-out resolution